These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32491855)

  • 21. Endosomolytic and Tumor-Penetrating Mesoporous Silica Nanoparticles for siRNA/miRNA Combination Cancer Therapy.
    Wang Y; Xie Y; Kilchrist KV; Li J; Duvall CL; Oupický D
    ACS Appl Mater Interfaces; 2020 Jan; 12(4):4308-4322. PubMed ID: 31939276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
    Reissmann S
    J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Codelivery of a miR-124 Mimic and Obatoclax by Cholesterol-Penetratin Micelles Simultaneously Induces Apoptosis and Inhibits Autophagic Flux in Breast Cancer in Vitro and in Vivo.
    Zhang N; Huang Y; Wu F; Zhao Y; Li X; Shen P; Yang L; Luo Y; Yang L; He G
    Mol Pharm; 2016 Jul; 13(7):2466-83. PubMed ID: 27266580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced intracellular peptide delivery by multivalent cell-penetrating peptide with bioreducible linkage.
    Kim H; Kitamatsu M; Ohtsuki T
    Bioorg Med Chem Lett; 2018 Feb; 28(3):378-381. PubMed ID: 29275934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein Delivery to Cytosol by Cell-Penetrating Peptide Bearing Tandem Repeat Penetration-Accelerating Sequence.
    Okuda A; Futaki S
    Methods Mol Biol; 2022; 2383():265-273. PubMed ID: 34766296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined apoptotic effects of peptide and miRNA in a peptide/miRNA nanocomplex.
    Kim H; Kitamatsu M; Ohtsuki T
    J Biosci Bioeng; 2019 Jul; 128(1):110-116. PubMed ID: 30718146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties.
    Soler M; González-Bártulos M; Soriano-Castell D; Ribas X; Costas M; Tebar F; Massaguer A; Feliu L; Planas M
    Org Biomol Chem; 2014 Mar; 12(10):1652-63. PubMed ID: 24480922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. α-Aminoisobutyric Acid-Containing Amphipathic Helical Peptide-Cyclic RGD Conjugation as a Potential Drug Delivery System for MicroRNA Replacement Therapy in Vitro.
    Taniguchi K; Wada SI; Ito Y; Hayashi J; Inomata Y; Lee SW; Tanaka T; Komura K; Akao Y; Urata H; Uchiyama K
    Mol Pharm; 2019 Nov; 16(11):4542-4550. PubMed ID: 31596588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A smart tumor targeting peptide-drug conjugate, pHLIP-SS-DOX: synthesis and cellular uptake on MCF-7 and MCF-7/Adr cells.
    Song Q; Chuan X; Chen B; He B; Zhang H; Dai W; Wang X; Zhang Q
    Drug Deliv; 2016 Jun; 23(5):1734-46. PubMed ID: 25853477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual peptide conjugation strategy for improved cellular uptake and mitochondria targeting.
    Lin R; Zhang P; Cheetham AG; Walston J; Abadir P; Cui H
    Bioconjug Chem; 2015 Jan; 26(1):71-7. PubMed ID: 25547808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of a non-cationic cell penetrating peptide derived from membrane-interacting human proteins and its potential as a protein delivery carrier.
    Young Kim H; Young Yum S; Jang G; Ahn DR
    Sci Rep; 2015 Jun; 5():11719. PubMed ID: 26114640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a mitochondrial-binding site on the N-terminal end of hexokinase II.
    Bryan N; Raisch KP
    Biosci Rep; 2015 Apr; 35(3):. PubMed ID: 26182367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).
    Jiao X; Zhao L; Ma M; Bai X; He M; Yan Y; Wang Y; Chen Q; Zhao X; Zhou M; Cui Z; Zheng Z; Wang E; Wei M
    Breast Cancer Res Treat; 2013 Jun; 139(3):717-30. PubMed ID: 23780685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Peptide- and Lipid-Based Delivery of miR-34a-5p Mimic into PPC-1 Cells.
    Urgard E; Brjalin A; Langel Ü; Pooga M; Rebane A; Annilo T
    Nucleic Acid Ther; 2017 Oct; 27(5):295-302. PubMed ID: 28657476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Turkish Propolis on miRNA Expression, Cell Cycle, and Apoptosis in Human Breast Cancer (MCF-7) Cells.
    Misir S; Aliyazicioglu Y; Demir S; Turan I; Hepokur C
    Nutr Cancer; 2020; 72(1):133-145. PubMed ID: 31112051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel cell-penetrating peptide targeting mitochondria.
    Cerrato CP; Pirisinu M; Vlachos EN; Langel Ü
    FASEB J; 2015 Nov; 29(11):4589-99. PubMed ID: 26195590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell.
    Liu J; Meng T; Yuan M; Wen L; Cheng B; Liu N; Huang X; Hong Y; Yuan H; Hu F
    Int J Nanomedicine; 2016; 11():6713-6725. PubMed ID: 28003747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pterostilbene induces mitochondrially derived apoptosis in breast cancer cells in vitro.
    Moon D; McCormack D; McDonald D; McFadden D
    J Surg Res; 2013 Apr; 180(2):208-15. PubMed ID: 22572619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Local microRNA delivery targets Palladin and prevents metastatic breast cancer.
    Gilam A; Conde J; Weissglas-Volkov D; Oliva N; Friedman E; Artzi N; Shomron N
    Nat Commun; 2016 Sep; 7():12868. PubMed ID: 27641360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bifunctional peptide hybrids targeting the matrix of mitochondria.
    Klimpel A; Neundorf I
    J Control Release; 2018 Dec; 291():147-156. PubMed ID: 30367921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.